Phase I Clinical Trial of Valacyclovir and Standard of Care Cyclophosphamide in Children With Endemic Burkitt Lymphoma in Malawi

Treatment options for Epstein-Barr virus (EBV)-associated Burkitt lymphoma in Africa are limited because of chemotherapy-associated toxicity. Since other EBV-associated diseases respond to antiviral agents, we investigated adding an antiviral agent, valacyclovir, to the current chemotherapy regimen...

Full description

Saved in:
Bibliographic Details
Main Authors: Olson, Dan, Gulley, Margaret L., Tang, Weihua, Wokocha, Clifford, Mechanic, Oren, Hosseinipour, Mina, Gold, Stuart H., Nguluwe, Nelson, Mwansambo, Charles, Shores, Carol
Format: Artigo
Language:Inglês
Published: 2012
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3654008/
https://ncbi.nlm.nih.gov/pubmed/23260601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2012.11.003
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items